ARWR logo

ARWR Total liabilities

annual total liabilities:

$948.74M+$470.35M(+98.32%)
September 30, 2024

Summary

  • As of today (May 29, 2025), ARWR annual total liabilities is $948.74 million, with the most recent change of +$470.35 million (+98.32%) on September 30, 2024.
  • During the last 3 years, ARWR annual total liabilities has risen by +$647.41 million (+214.85%).
  • ARWR annual total liabilities is now at all-time high.

Performance

ARWR Total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRbalance sheet metrics

quarterly total liabilities:

$889.27M-$68.35M(-7.14%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ARWR quarterly total liabilities is $889.27 million, with the most recent change of -$68.35 million (-7.14%) on March 31, 2025.
  • Over the past year, ARWR quarterly total liabilities has increased by +$429.53 million (+93.43%).
  • ARWR quarterly total liabilities is now -7.14% below its all-time high of $957.62 million, reached on December 31, 2024.

Performance

ARWR quarterly total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRbalance sheet metrics

Total liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

ARWR Total liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+98.3%+93.4%
3 y3 years+214.8%+253.9%
5 y5 years+796.6%+1217.2%

ARWR Total liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+246.8%-7.1%+253.9%
5 y5-yearat high+1462.3%-7.1%+1885.9%
alltimeall timeat high>+9999.0%-7.1%>+9999.0%

ARWR Total liabilities History

DateAnnualQuarterly
Mar 2025
-
$889.27M(-7.1%)
Dec 2024
-
$957.62M(+0.9%)
Sep 2024
$948.74M(+98.3%)
$948.74M(+74.1%)
Jun 2024
-
$544.78M(+18.5%)
Mar 2024
-
$459.75M(+1.6%)
Dec 2023
-
$452.57M(-5.4%)
Sep 2023
$478.39M(+74.9%)
$478.39M(+15.6%)
Jun 2023
-
$413.87M(-2.9%)
Mar 2023
-
$426.20M(-13.9%)
Dec 2022
-
$495.12M(+81.0%)
Sep 2022
$273.60M(-9.2%)
$273.60M(-1.4%)
Jun 2022
-
$277.61M(+10.5%)
Mar 2022
-
$251.31M(-5.5%)
Dec 2021
-
$265.98M(-11.7%)
Sep 2021
$301.33M(+396.2%)
$301.33M(+1.1%)
Jun 2021
-
$298.04M(-4.2%)
Mar 2021
-
$311.25M(+595.1%)
Dec 2020
-
$44.78M(-26.3%)
Sep 2020
$60.73M(-42.6%)
$60.73M(-3.8%)
Jun 2020
-
$63.14M(-6.5%)
Mar 2020
-
$67.51M(-23.3%)
Dec 2019
-
$88.07M(-16.8%)
Sep 2019
$105.81M(+546.4%)
$105.81M(-4.8%)
Jun 2019
-
$111.16M(-16.6%)
Mar 2019
-
$133.30M(-21.3%)
Dec 2018
-
$169.45M(+935.2%)
Sep 2018
$16.37M(-29.3%)
$16.37M(+46.9%)
Jun 2018
-
$11.14M(-16.1%)
Mar 2018
-
$13.28M(-26.3%)
Dec 2017
-
$18.02M(-22.2%)
Sep 2017
$23.16M(-30.2%)
$23.16M(-9.3%)
Jun 2017
-
$25.54M(-23.8%)
Mar 2017
-
$33.54M(-28.7%)
Dec 2016
-
$47.05M(+41.9%)
Sep 2016
$33.15M(+46.4%)
$33.15M(+27.0%)
Jun 2016
-
$26.11M(+26.2%)
Mar 2016
-
$20.68M(+8.8%)
Dec 2015
-
$19.01M(-16.0%)
Sep 2015
$22.65M(+34.5%)
$22.65M(+56.8%)
Jun 2015
-
$14.45M(-20.5%)
Mar 2015
-
$18.18M(+10.7%)
Dec 2014
-
$16.43M(-2.4%)
Sep 2014
$16.83M(+45.2%)
$16.83M(+55.6%)
Jun 2014
-
$10.82M(-17.5%)
Mar 2014
-
$13.10M(+11.2%)
Dec 2013
-
$11.78M(+1.6%)
Sep 2013
$11.59M(+50.2%)
$11.59M(+41.7%)
Jun 2013
-
$8.18M(-5.5%)
Mar 2013
-
$8.66M(+13.5%)
Dec 2012
-
$7.63M(-1.2%)
Sep 2012
$7.72M
$7.72M(-4.0%)
Jun 2012
-
$8.04M(-5.6%)
DateAnnualQuarterly
Mar 2012
-
$8.51M(+16.4%)
Dec 2011
-
$7.31M(+120.0%)
Sep 2011
$3.32M(-22.3%)
$3.32M(+22.2%)
Jun 2011
-
$2.72M(-9.8%)
Mar 2011
-
$3.01M(-61.8%)
Dec 2010
-
$7.90M(+84.8%)
Sep 2010
$4.28M(+50.3%)
$4.28M(-16.8%)
Jun 2010
-
$5.14M(+125.5%)
Mar 2010
-
$2.28M(-11.6%)
Dec 2009
-
$2.58M(-9.3%)
Sep 2009
$2.84M(-42.6%)
$2.84M(-36.6%)
Jun 2009
-
$4.48M(-54.1%)
Mar 2009
-
$9.76M(-6.0%)
Dec 2008
-
$10.39M(+109.8%)
Sep 2008
$4.95M(+45.8%)
$4.95M(+62.1%)
Jun 2008
-
$3.06M(+9.4%)
Mar 2008
-
$2.79M(+0.4%)
Dec 2007
-
$2.78M(-18.0%)
Sep 2007
$3.40M(+16.3%)
$3.40M(+15.5%)
Jun 2007
-
$2.94M(+156.5%)
Mar 2007
-
$1.15M(+12.9%)
Dec 2006
-
$1.02M(-65.2%)
Sep 2006
$2.92M(+185.1%)
$2.92M(+68.9%)
Jun 2006
-
$1.73M(-33.2%)
Mar 2006
-
$2.59M(+77.8%)
Dec 2005
-
$1.46M(+42.2%)
Sep 2005
$1.02M(+48.5%)
$1.02M(+3.2%)
Jun 2005
-
$992.70K(+71.4%)
Mar 2005
-
$579.20K(+64.6%)
Dec 2004
-
$351.90K(-49.0%)
Sep 2004
$689.70K(+616.9%)
$689.70K(+84.9%)
Jun 2004
-
$373.00K(+871.4%)
Mar 2004
-
$38.40K(+89.2%)
Dec 2003
-
$20.30K(-78.9%)
Sep 2003
$96.20K(-94.0%)
$96.20K(-94.7%)
Jun 2003
-
$1.80M(+3.2%)
Mar 2003
-
$1.74M(+6.1%)
Dec 2002
-
$1.64M(+1.8%)
Sep 2002
$1.61M(+19.5%)
$1.61M(+2.7%)
Jun 2002
-
$1.57M(+10.0%)
Mar 2002
-
$1.43M(+0.8%)
Dec 2001
-
$1.42M(+4.8%)
Sep 2001
$1.35M(+13.1%)
$1.35M(+3.8%)
Jun 2001
-
$1.30M(+2.5%)
Mar 2001
-
$1.27M(+3.9%)
Dec 2000
-
$1.22M(+2.3%)
Sep 2000
$1.19M(+10.7%)
$1.19M(-2.9%)
Jun 2000
-
$1.23M(+4.7%)
Mar 2000
-
$1.18M(+4.6%)
Dec 1999
-
$1.12M
Sep 1999
$1.08M(-62.6%)
-
Sep 1998
$2.88M(+7.4%)
-
Sep 1997
$2.68M
-

FAQ

  • What is Arrowhead Pharmaceuticals annual total liabilities?
  • What is the all time high annual total liabilities for Arrowhead Pharmaceuticals?
  • What is Arrowhead Pharmaceuticals annual total liabilities year-on-year change?
  • What is Arrowhead Pharmaceuticals quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Arrowhead Pharmaceuticals?
  • What is Arrowhead Pharmaceuticals quarterly total liabilities year-on-year change?

What is Arrowhead Pharmaceuticals annual total liabilities?

The current annual total liabilities of ARWR is $948.74M

What is the all time high annual total liabilities for Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals all-time high annual total liabilities is $948.74M

What is Arrowhead Pharmaceuticals annual total liabilities year-on-year change?

Over the past year, ARWR annual total liabilities has changed by +$470.35M (+98.32%)

What is Arrowhead Pharmaceuticals quarterly total liabilities?

The current quarterly total liabilities of ARWR is $889.27M

What is the all time high quarterly total liabilities for Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals all-time high quarterly total liabilities is $957.62M

What is Arrowhead Pharmaceuticals quarterly total liabilities year-on-year change?

Over the past year, ARWR quarterly total liabilities has changed by +$429.53M (+93.43%)
On this page